The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA) Special
Issue Writing Committee is charged with reviewing, updating, and categorizing indications …

Several genes have been implicated in genetic forms of nephrotic syndrome occurring in
children. It is now known that the phenotypes associated with mutations in these genes …

The American Society for Apheresis (ASFA) JCA Special Issue Writing Committee is
charged with reviewing, updating and categorizating indications for therapeutic apheresis …

Results Among 11,742 kidney transplant recipients screened for FSGS, 176 had a diagnosis
of idiopathic FSGS and were included. FSGS recurred in 57 patients (32%; 95% confidence …

Thirty to fifty percent of kidney transplant recipients have glomerular diseases as the
underlying causes of end-stage renal failure. While recurrence of glomerulonephritis is an …

Most of the diseases for which apheresis therapy is indicated are intractable and rare, and
each patient has a different background and treatment course prior to apheresis therapy …

Idiopathic NS (nephrotic syndrome) is characterized by massive proteinuria, due to a leak in
the glomerular barrier to proteins. Genetic defects that affect the function and the …

Podocin mutations (NPHS2 gene) are responsible for the autosomal recessive form of
steroid-resistant nephrotic syndrome. As a result of a screening for these gene alterations in …

The term idiopathic nephrotic syndrome (iNS) traditionally covers minimal change disease
and primary focal segmental glomerulosclerosis (FSGS), now thought to be separate …

Focal segmental glomerular sclerosis (FSGS) is a pathological term to indicate glomerular
lesions associated with distinctive clinical features. In most cases, FSGS is primary in nature …